About
EyePoint Pharmaceuticals develops and commercializes therapeutics for serious retinal diseases, using proprietary Durasert technology for sustained intraocular drug delivery.
Explore EyePoint Pharmaceuticals, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.